Commentary: A Huge Leap for Microscopic Health Treatments
WHEN CLEVELAND CLINIC first entered discussions with Hebrew University about a collaboration in nanoscience in 2016, I must admit I did not have extremely high expectations.
Although I was well aware of the University's excellent reputation, I was mindful of the long distance between the institutions, which typically doesn't lend well to fruitful partnerships.
The task we faced was daunting: Combining forces, nearly 6,000 miles apart, to create and commercialize new therapies, technologies and drug-delivery systems. Using particles too small for the naked eye to see, our goal was to utilize molecular-level engineering to target medications to ...